The Fort Worth Press - Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare

USD -
AED 3.672498
AFN 64.00007
ALL 83.571528
AMD 379.306739
ANG 1.790083
AOA 917.000049
ARS 1394.401798
AUD 1.419557
AWG 1.8
AZN 1.699521
BAM 1.70403
BBD 2.026631
BDT 123.441516
BGN 1.709309
BHD 0.377734
BIF 2983.464413
BMD 1
BND 1.284852
BOB 6.95265
BRL 5.245323
BSD 1.006257
BTN 93.307018
BWP 13.64595
BYN 3.067036
BYR 19600
BZD 2.023756
CAD 1.37396
CDF 2269.999836
CHF 0.792095
CLF 0.023189
CLP 915.629756
CNY 6.87305
CNH 6.904975
COP 3708.35
CRC 469.967975
CUC 1
CUP 26.5
CVE 96.081456
CZK 21.364991
DJF 179.186419
DKK 6.51834
DOP 60.835276
DZD 132.69298
EGP 52.238399
ERN 15
ETB 157.116838
EUR 0.87232
FJD 2.218797
FKP 0.750673
GBP 0.75389
GEL 2.715053
GGP 0.750673
GHS 10.968788
GIP 0.750673
GMD 73.999768
GNF 8818.979979
GTQ 7.707255
GYD 210.505219
HKD 7.835445
HNL 26.6321
HRK 6.573697
HTG 131.875123
HUF 343.269791
IDR 16981
ILS 3.11554
IMP 0.750673
INR 93.274199
IQD 1318.032101
IRR 1314999.999547
ISK 124.920163
JEP 0.750673
JMD 157.992201
JOD 0.709015
JPY 159.103695
KES 129.654127
KGS 87.449827
KHR 4029.54184
KMF 428.000148
KPW 899.987979
KRW 1497.984956
KWD 0.30681
KYD 0.838475
KZT 485.403559
LAK 21591.404221
LBP 90120.825254
LKR 313.313697
LRD 184.128893
LSL 16.795929
LTL 2.952741
LVL 0.60489
LYD 6.420803
MAD 9.415922
MDL 17.543921
MGA 4190.776631
MKD 53.805494
MMK 2099.739449
MNT 3585.842291
MOP 8.123072
MRU 40.161217
MUR 46.509909
MVR 15.46001
MWK 1744.806191
MXN 17.824296
MYR 3.933498
MZN 63.912009
NAD 16.795929
NGN 1362.930023
NIO 37.027516
NOK 9.56597
NPR 149.303937
NZD 1.71902
OMR 0.384497
PAB 1.006169
PEN 3.436114
PGK 4.341518
PHP 60.083966
PKR 281.091833
PLN 3.73276
PYG 6503.590351
QAR 3.658789
RON 4.446602
RSD 102.459011
RUB 86.273875
RWF 1468.813316
SAR 3.755371
SBD 8.04524
SCR 13.624922
SDG 600.999929
SEK 9.389825
SGD 1.282845
SHP 0.750259
SLE 24.649774
SLL 20969.510825
SOS 575.063724
SRD 37.375021
STD 20697.981008
STN 21.350297
SVC 8.803744
SYP 110.528765
SZL 16.800579
THB 32.766985
TJS 9.62383
TMT 3.5
TND 2.960823
TOP 2.40776
TRY 44.320801
TTD 6.820677
TWD 31.91301
TZS 2599.979657
UAH 44.250993
UGX 3785.225075
UYU 40.745194
UZS 12269.740855
VES 450.94284
VND 26300
VUV 119.408419
WST 2.73222
XAF 571.627633
XAG 0.014011
XAU 0.000213
XCD 2.70255
XCG 1.813334
XDR 0.710924
XOF 571.630124
XPF 103.919416
YER 238.575035
ZAR 16.949765
ZMK 9001.21184
ZMW 19.677217
ZWL 321.999592
  • RBGPF

    0.1000

    82.5

    +0.12%

  • CMSC

    -0.1200

    22.83

    -0.53%

  • GSK

    -1.3500

    52.06

    -2.59%

  • RIO

    -2.0800

    87.72

    -2.37%

  • NGG

    -3.0200

    87.4

    -3.46%

  • BCC

    -1.0800

    71.84

    -1.5%

  • BCE

    -0.2600

    25.75

    -1.01%

  • CMSD

    0.0100

    22.89

    +0.04%

  • AZN

    -2.8700

    188.42

    -1.52%

  • RELX

    -0.4300

    33.86

    -1.27%

  • RYCEF

    -0.2100

    16.6

    -1.27%

  • BTI

    -2.4600

    58.09

    -4.23%

  • JRI

    -0.1370

    12.323

    -1.11%

  • BP

    0.7600

    44.61

    +1.7%

  • VOD

    -0.3800

    14.37

    -2.64%

Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare
Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare

Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare

LAS VEGAS, NV / ACCESS Newswire / March 10, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that Apollo Hospitals (Apollo) and Ainnova have officially established a strategic collaboration that marks a significant step forward in the integration of artificial intelligence into disease detection and prediction.

Text size:

As part of this alliance, Ainnova has secured an exclusive license for several advanced AI algorithms, which have been rigorously validated with over 2.3 million data points and now form an integral part of Ainnova's Vision AI platform. These cutting-edge solutions enable the early and precise detection of conditions, such as cardiovascular disease (CVD), chronic kidney disease (CKD), liver fibrosis, type 2 Diabetes, and lung abnormalities in CT scans and X-rays, including lung cancer.

Last month, Avant and Ainnova signed a global development and licensing deal for Ai-Nova Acquisition Corp. (AAC), the joint venture formed by both companies. Given AAC's territory now includes a global license to develop and market Ainnova's technology portfolio, this partnership with Apollo strengthens the joint venture's efforts to advance AI in Healthcare using Ainnova's Vision AI platform and its proprietary versatile retinal camera technology.

This week, most of these AI-driven diagnostics will be available exclusively on the Vision AI platform across the Americas, where the first commercial pilot programs are set to launch in the coming weeks.

Notably, Brazil is already included in the expansion roadmap, as the partnership has successfully met the regulatory requirements set by ANVISA (Brazilian Health Regulatory Agency). This milestone paves the way for commercialization in a country with over 200-million people.

The integration of these AI-powered solutions aligns with efforts to enhance chronic disease management by adding substantial value to patient care. By providing a comprehensive preventive health assessment, these tools aim to facilitate early referrals from primary care providers or community health services, such as pharmacies, to specialized medical professionals.

Apollo Hospitals is one of the largest and most renowned private healthcare networks in Asia, playing a leading role in transforming healthcare in India and across Southeast Asia. With a robust presence that includes hospitals, clinics, pharmacies, and diagnostic centers in the region and beyond, Apollo remains at the forefront of medical innovation.

With this alliance, Apollo reaffirms its commitment to advancing global healthcare by leveraging AI-powered solutions. Partnering with Ainnova in the Americas underscores its dedication to driving innovation, improving patient outcomes, and expanding access to state-of-the-art medical technologies. Together, the two organizations will continue to develop and deploy AI-driven healthcare solutions with additional innovations set to be introduced in the near future.

About Ainnova Tech, Inc.

Ainnova is a Nevada-based healthtech startup with headquarters in San Jose, Costa Rica, and Houston, Texas. Founded by an experienced and innovative team that is dedicated to leveraging artificial intelligence for early disease detection. Recognized with multiple global awards and renowned partnerships with hospitals and medical device companies, we proudly introduce VisionAI - our cutting-edge platform designed to prevent blindness and detect the early onset of diabetes. Explore how Ainnova is revolutionizing healthcare through advanced technology and proactive solutions.

About Apollo Hospitals

Apollo revolutionized healthcare when Dr. Prathap Reddy opened the first hospital in Chennai in 1983. Today, Apollo is India's largest integrated healthcare platform with over 10,000 beds across 73 hospitals, over 6000 pharmacies and over 200 clinics and diagnostic centers, as well as 150 telemedicine centers. It is the world's leading cardiac center with over 200,000 surgeries and the world's largest private cancer care provider. Apollo continues to invest in research to bring the most cutting-edge technologies, equipment, and treatment protocols to ensure patients have the best available care in the world. Apollo's 100,000 family members are dedicated to bringing you the best care and leaving the world better than we found it.

About Avant Technologies, Inc.

Avant Technologies, Inc. is an emerging technology company developing solutions in artificial intelligence in healthcare. With a focus on pushing the boundaries of what is possible in AI and machine learning, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology.

More information about Avant can be found at https://avanttechnologies.com

You can also follow us on social media at:

https://twitter.com/AvantTechAI

https://www.linkedin.com/company/avant-technologies-ai

https://www.facebook.com/AvantTechAI

https://www.youtube.com/@AvantTechAI

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements because of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date after the date of the press release.

Contact:

Avant Technologies, Inc.
[email protected]

SOURCE: Avant Technologies



View the original press release on ACCESS Newswire

T.Mason--TFWP